News | September 19, 2014

Tops Breast Center Reader Study Compares Prospective Tomosynthesis Interpretations With Retrospective Readings of the Corresponding FFDM

Tops Breast Center Study Tomosynthesis FFDM

September 19, 2014 — Tops Comprehensive Breast Center, Houston, was a part of a recent study conducted by Stephen L. Rose, M.D., medical director of Tops Comprehensive Breast Center, and colleagues (Andra L. Tidwell, BSRT (R)(M); Mary F. Ice, M.D.; Amy S. Nordmann, M.D.; Russell Sexton Jr., DO; Rui Song, M.D.) conducted exclusively at Tops, leading to advancements in screening mammography and 3-D mammography.

In the United States, women have routine full-field digital mammography (FFDM). This exam, while widely accepted, has known pitfalls when it comes to high recall rates and low cancer detection when used as the sole screening method. While new screening tools are constantly being tested and discovered for early detection, digital breast tomosynthesis (DBT) has been proven as one of the better approaches. DBT enables the reconstruction of cross-sectional images aimed to assist radiologists with the interpretation process through better visualization of breast tissue.

Rose and colleagues set out to compare performance of prospective interpretations of clinical tomosynthesis (DBT) plus FFDM examinations with retrospective readings of the corresponding FFDM examinations alone.

For the study, seven Mammography Quality Standard Act-qualified radiologists interpreted 10,878 FFDM examinations that had been interpreted by other radiologists using a combination of FFDM and DBT. When comparing recall rates between the two clinical interpretations, those interpretations that had utilized both FFDM and DBT recalled 588 cases; compared to those that depended only on FFDM where 888 cases were recalled.

While none of the technologies used currently are perfect, it is hard to deny the benefit of FFDM and DBT together to exclude outliers and identify more clearly which screenings will indeed require a diagnostic work up. The consistency of the findings for the group was not only encouraging, but also a confidence builder that the combination of DBT plus FFDM for screening women resulted in a 35 percentreduction in recall rates and a simultaneous increase in cancer detection rates when compared to retrospective interpretations of corresponding FFDM examinations alone. The study showed an increase of 55 percent more cancers were found than digital mammography alone and increased detection of invasive cancers by 66 percent.

Rose stated, “This study should put to rest much of the current confusion over the benefits of mammography. With this new technology, tomosynthesis (3-D mammography), we can significantly reduce the patient anxiety generated by recalls for additional imaging. Simultaneously, the new technology will increase the accuracy of traditional digital mammography in the early detection of invasive tumors.”

Rose and Andra Tidwell, BSRT, imaging director of Tops Comprehensive Breast Center, also published a study last year in the American Journal of Radiology comparing 3-D screening with the prior year’s standard digital mammography. The study actually demonstrated a 37 percent reduction in recalls and over a 50 percent increase in the early detection of invasive tumors. “I truly believe that as experience grows with 3-D mammography, we will see the recall rates continue to drop, and we will detect tumors earlier when less treatment is required. This is a very exciting study for all women undergoing screening mammography,” stated Rose.

Tops Comprehensive Breast Center has served the North Houston area for more than 10 years and has a team passionately devoted to providing patients with high quality breast care. Tops Comprehensive Breast Center, with locations in North Houston, Willowbrook, Kingwood and The Woodlands, is recognized as a Breast Imaging Center of Excellence by American College of Radiology (ACR). Tops Comprehensive Breast Center is affiliated with Tops Surgical Specialty Hospital, a patient centered, physician driven healthcare facility managed by United Surgical Partners International. Both the Hospital and Breast Centers are committed to their mission: To provide first-class surgical services for the local community in a safe, comfortable and welcoming environment; one in which we would be happy to treat our own families.

For more information:

Related Content

Doctor-Patient Discussions Neglect Potential Harms of Lung Cancer Screening
News | Lung Cancer | August 15, 2018
August 15, 2018 — Although national guidelines advise doctors to discuss the benefits and harms of...
Illinois Governor Approves State Breast Density Reporting Bill Into Law
News | Breast Density | August 13, 2018
Illinois Gov. Bruce Rauner approved the Illinois Breast Density Reporting Law (Public Act 100-0749) on Aug. 10, 2018...
PET Tracer Identifies Estrogen Receptor Expression Differences in Breast Cancer Patients
News | PET Imaging | August 09, 2018
In metastatic breast cancer, prognosis and treatment is largely influenced by estrogen receptor (ER) expression of the...
iCAD Receives FDA Clearance of PowerLook Density Assessment for Digital Breast Tomosynthesis
Technology | Breast Density | August 08, 2018
iCAD announced U.S. Food and Drug Administration (FDA) clearance of its latest artificial intelligence (AI) software...
Cardiac Imaging Reveals Roots of Preeclampsia Damage in Pregnant Women
News | Women's Health | August 07, 2018
Johns Hopkins researchers say a heart imaging study of scores of pregnant women with the most severe and dangerous form...
Cardiac Monitoring a Higher Priority for High-Risk Breast Cancer Patients
News | Cardio-oncology | August 07, 2018
August 7, 2018 — While heart failure is an uncommon complication of...
Hologic Acquires Digital Specimen Radiography Company Faxitron Bioptics

VisionCT 3-D breast specimen-designated computed tomography (CT) system. Image courtesy of Faxitron Bioptics.

News | Breast Imaging | July 31, 2018
Hologic Inc. announced it has completed the acquisition of Faxitron Bioptics, a privately-held leader in digital...
Konica Minolta Hosting Lunch and Learn at 23rd Annual Mammography Meeting in Santa Fe
News | Breast Imaging | July 31, 2018
Konica Minolta Healthcare Americas Inc. will sponsor a lunch and learn featuring its Exa Mammo platform during the 23rd...
FDA Approves New Tomosynthesis Quality Control Tests for ACR Digital Mammography QC Manual
News | Mammography | July 30, 2018
The U.S. Food and Drug Administration (FDA) recently approved the American College of Radiology’s (ACR’s) amendment to...
The Magtrace and Sentimag Magnetic Localization System uses magnetic detection during sentinel lymph node biopsy procedures to identify specific lymph nodes, known as sentinel lymph nodes, for surgical removal. The FDA granted approval of the Sentimag System to Endomagnetics Inc.

The  Endomagnetics' Magtrace and Sentimag Magnetic Localization System uses magnetic detection during sentinel lymph node biopsy procedures to identify specific lymph nodes, known as sentinel lymph nodes, for surgical removal.

Technology | Women's Health | July 24, 2018
July 24, 2018 — The U.S.
Overlay Init